about
Cordon-bleu is an actin nucleation factor and controls neuronal morphologyF-BAR proteins of the syndapin family shape the plasma membrane and are crucial for neuromorphogenesisRegulation of N-WASP and the Arp2/3 complex by Abp1 controls neuronal morphologyEHD proteins associate with syndapin I and II and such interactions play a crucial role in endosomal recycling.Nek9 phosphorylation of NEDD1/GCP-WD contributes to Plk1 control of γ-tubulin recruitment to the mitotic centrosome.The role of NEDD1 phosphorylation by Aurora A in chromosomal microtubule nucleation and spindle function.Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.Integration of genomic information in the clinical management of HCC.Molecular profiling of liver tumors: classification and clinical translation for decision making.IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.Hepatocellular carcinoma: genome-scale metabolic models for hepatocellular carcinoma.DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma.Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trialImmune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCCR-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent MannerMolecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trialsAn Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive AgentsPlatelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
P50
Q28565024-2254CBF1-8CAE-4983-814B-CCA185C4B2D0Q28582996-9D56802C-6EEF-41BB-B92B-ACB14C8D5B4EQ33283511-8CDD6BFA-000C-4A00-A9EB-E5A2BFD72A22Q33911110-8E1B2D33-BF6C-4C53-BDC4-004A3BFA857DQ34289492-4AEFCCE1-AFE8-4EF4-8E25-B06D057F9CDAQ34319953-021B275C-BE7F-48B2-AA59-1C2BDBE68EEEQ36104399-7186AA7D-CA87-405B-8414-AEC09B5515E8Q38254696-BC6FBED8-590F-4BE0-A0EB-13FD0EC405CDQ38264952-1BFE67FB-D8C7-4950-8BB3-91074D5FB93FQ38747068-1872D30D-B25C-453F-92E0-A8058FFCC7ECQ38917883-DE31F917-9890-42FC-84CC-DB2A9EB57DABQ51084656-98BD678B-BD5E-4922-AFD1-5F103BE5582FQ51499838-16E3449E-7300-4B62-92CC-882E15AF058AQ54350113-D2DD18A6-80DD-40DC-ACDF-ABBE115C8544Q58020775-4D553801-604A-45FC-86DA-C5F204674490Q90928640-9E05E856-D0BC-4C54-8DA4-0D40BC3C578AQ91178796-ACE03063-35CD-44D2-85AB-B1C7CF9AE302Q91723916-8D8E7F7E-08B0-42D5-A2D6-1688EC6B9059Q92175242-34E74562-D998-4A80-A4A9-800FFA8CC178Q92768065-3CA83602-EAF0-47F0-B828-D3CD4600F13F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roser Pinyol
@ast
Roser Pinyol
@en
Roser Pinyol
@es
Roser Pinyol
@nl
Roser Pinyol
@sl
type
label
Roser Pinyol
@ast
Roser Pinyol
@en
Roser Pinyol
@es
Roser Pinyol
@nl
Roser Pinyol
@sl
prefLabel
Roser Pinyol
@ast
Roser Pinyol
@en
Roser Pinyol
@es
Roser Pinyol
@nl
Roser Pinyol
@sl
P106
P31
P496
0000-0002-0288-6314